当前位置:首页 - 行情中心 - 康辰药业(603590) - 财务分析 - 现金流量表

康辰药业

(603590)

  

流通市值:55.47亿  总市值:55.75亿
流通股本:1.58亿   总股本:1.59亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金233,628,917.31969,690,499.75681,399,880.97395,655,319.72
  收到其他与经营活动有关的现金11,282,483.5722,339,267.0224,619,689.7911,447,932.94
  经营活动现金流入小计244,911,400.88992,029,766.77706,019,570.76407,103,252.66
  购买商品、接受劳务支付的现金10,286,426.0757,070,828.9845,825,704.8831,440,009.12
  支付给职工以及为职工支付的现金98,136,844.51291,533,574.94222,821,457.01153,431,689.28
  支付的各项税费30,128,372.484,954,042.9758,129,441.7531,957,530.68
  支付其他与经营活动有关的现金85,762,793.44442,792,971.79295,343,717.02201,951,157.3
  经营活动现金流出小计224,314,436.42876,351,418.68622,120,320.66418,780,386.38
  经营活动产生的现金流量净额20,596,964.46115,678,348.0983,899,250.1-11,677,133.72
二、投资活动产生的现金流量:
  收回投资收到的现金515,215,411.051,191,644,814.091,001,144,814.09820,000,000
  取得投资收益收到的现金2,617,956.1521,194,350.2512,288,287.3411,419,895.41
  处置固定资产、无形资产和其他长期资产收回的现金净额-608,320607,970155,000
  投资活动现金流入小计517,833,367.21,213,447,484.341,014,041,071.43831,574,895.41
  购建固定资产、无形资产和其他长期资产支付的现金8,951,421.6853,449,655.0244,853,149.4827,583,874.14
  投资支付的现金470,009,768.721,115,705,642.33900,500,000560,000,000
  投资活动现金流出小计478,961,190.41,169,155,297.35945,353,149.48587,583,874.14
  投资活动产生的现金流量净额38,872,176.844,292,186.9968,687,921.95243,991,021.27
三、筹资活动产生的现金流量:
  取得借款收到的现金43,974,915298,867,756.47256,505,696.4784,705,761.62
  筹资活动现金流入小计43,974,915298,867,756.47256,505,696.4784,705,761.62
  偿还债务支付的现金31,548,768180,456,251.99179,434,554.9935,995,679.14
  分配股利、利润或偿付利息支付的现金2,099,068.23102,394,062.77100,432,320.198,533,179.92
  支付其他与筹资活动有关的现金44,922,189.2133,366,058.1211,339,121.986,161,508.31
  筹资活动现金流出小计78,570,025.44316,216,372.88291,205,997.07140,690,367.37
  筹资活动产生的现金流量净额-34,595,110.44-17,348,616.41-34,700,300.6-55,984,605.75
四、汇率变动对现金及现金等价物的影响-84,904.01-26,524.81-1,701.257,729.74
五、现金及现金等价物净增加额24,789,126.81142,595,393.86117,885,170.2176,337,011.54
  加:期初现金及现金等价物余额332,573,095.7189,977,701.84189,977,701.84189,977,701.84
  期末现金及现金等价物余额357,362,222.51332,573,095.7307,862,872.04366,314,713.38
补充资料:
  净利润-169,423,424.87-96,334,639.19
  固定资产和投资性房地产折旧-23,218,315.68-10,238,902.29
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-23,218,315.68-10,238,902.29
  无形资产摊销-10,165,790.6-5,104,167.39
  长期待摊费用摊销-209,165.71-104,582.85
  处置固定资产、无形资产和其他长期资产的损失-486,253.58--130,668.15
  固定资产报废损失-86,116.76--
  公允价值变动损失--4,176,636.3--379,689.56
  财务费用-7,486,033.79-3,317,561.87
  投资损失--17,697,524--10,015,947.42
  递延所得税-8,146,394.65-5,425,652.75
  其中:递延所得税资产减少-6,335,971.31-5,658,086.96
    递延所得税负债增加-1,810,423.34--232,434.21
  存货的减少-17,912,759.82-2,862,145.22
  经营性应收项目的减少--62,363,678.78--89,917,750.62
  经营性应付项目的增加--63,631,785.3--52,540,620.67
  其他-8,982,181.16-4,099,873.13
  现金的期末余额-332,573,095.7-366,314,713.38
  减:现金的期初余额-189,977,701.84-189,977,701.84
  现金及现金等价物的净增加额-142,595,393.86-176,337,011.54
公告日期2026-04-232026-04-232025-10-302025-08-28
审计意见(境内)标准无保留意见
TOP↑